Dear colleagues: Welcome to the March 2018 issue of The Journal of Clinical and Aesthetic Dermatology (JCAD). We start this issue with a study titled “Double-blind, Placebo-controlled Trial to Evaluate
by Linda S. Marcus, MD Dr. Marcus is the Director of Dermatology Valley Hospital in Ridgewood, New Jersey. Funding/financial disclosures: The author has no conflicts of interest relevant to the content of
by Chee-Leok Goh, MD, MBBS, MRCP(UK), MMed(Int Med); Sai Yee Chuah, MBChB (Glasgow), MRCP(UK), Dip Derm, MRCPS (Glasgow); Steven Tien, MD; Guan Thng, MBBS, MRCP; María Alejandra Vitale, MD; and
by Esther RoE, PhD; Esther Serra, PhD; German Guzman, PhD; and Ignacio Sajoux, PhD Drs. Roe and Serra are with the Dermatology Department at the Hospital de la Santa Creu
by Rebecca F. Wang, BA; Myron Zhang, MD; Allireza Alloo, MD; Thomas Stasko, MD; Jordan E. Miller, BA; and Jessica A. Kaffenberger, MD Ms. Wang and Drs. Zhang and Kaffenberger
by Iliana A. Rahimi, BSc; Igor Eberhard, PhD; and Erich Kasten, PhD Mrs. Rahimi and Professor Kasten are with the Medical School hamburg in Hamburg, Germany. Dr. Eberhard is with
by Emily Lenczowski, BS; and Madhu Dahiya, MD Ms. Lenczowski is with the Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. Dr. Dahiya is with the Department of
by Kelly Segars, DO; Hassie Cooper, DO; Daniel J. Hogan, MD, FAAD; Richard Miller, DO, FAOCD; Michael Heaphy, Jr., MD, FAAD; and James Spencer, MD, FAAD Dr. Segars is with
by Natnicha Girdwichai, MD; Kumutnart Chanprapaph, MD; and Vasanop Vachiramon, MD Drs. Girdwichai, Chanprapaph, and Vachiramon are with the Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University in